Drug Database
Back to search

Poland· PL-100394527

Neoparin Forte

A enoxaparin product containing enoxaparinum natricum, registered in Poland by SciencePharma Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC B01AB05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNeoparin ForteATCB01AB05REGISTER NO.PL-100394527PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about enoxaparinum natricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Enoxaparin is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search enoxaparin products by name

Enoxaparin · ATC B01AB05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Enoxaparinum natricum
Manufacturer
SciencePharma Sp. z o.o.
Country
Poland (PL)
ATC code
B01AB05
ATC class
Enoxaparin
Defined daily dose
2 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 8

1 priced
  • gtin
    05906395161225
  • gtin
    05906395161164
    10 amp.-strz.
    PLN 290.69
  • gtin
    05906395161232
  • gtin
    05906395161249
  • gtin
    05906395161256
  • gtin
    05906395161140
  • gtin
    05906395161171
  • gtin
    05906395161157

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for enoxaparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check enoxaparin against other medicinesHow interaction checks work

Enoxaparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Enoxaparin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enoxaparin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/23a0d5e1-9e98-41ad-97aa-b13b63ac081f
GET /v1/drugs/23a0d5e1-9e98-41ad-97aa-b13b63ac081f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "15 000 j.m. (150 mg)/ml",
  "packaging": "05906395161225 ¦ Rp ¦ 124598\n2 amp.-strzyk. 1 ml z zabezpieczeniem igły\n05906395161232 ¦ Rp ¦ 124599\n6 amp.-strzyk. 1 ml z zabezpieczeniem igły\n05906395161249 ¦ Rp ¦ 124600\n10 amp.-strzyk. 1 ml z zabezpieczeniem igły\n05906395161256 ¦ Rp ¦ 124601\n30 amp.-strzyk. 1 ml z zabezpieczeniem igły\n05906395161140 ¦ Rp ¦ 126362\n2 amp.-strzyk. 1 ml\n05906395161164 ¦ Rp ¦ 126363\n10 amp.-strzyk. 1 ml\n05906395161171 ¦ Rp ¦ 126364\n30 amp.-strzyk. 1 ml\n05906395161157 ¦ Rp ¦ 126365\n6 amp.-strzyk. 1 ml",
  "substance": "Enoxaparinum natricum 150 mg",
  "common_name": "Enoxaparinum natricum",
  "pl_product_id": "100394527",
  "pozwolenie_nr": "24491",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about enoxaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console